Vimarsana
Biggest News Aggregation in the World

Page 38 - Cm Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cm Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cm Management Today - Breaking & Trending Today

Bright Health Group (NYSE:BHG) Stock Rating Upgraded by Zacks Investment Research - Vimarsana News

Bright Health Group (NYSE:BHG) Stock Rating Upgraded by Zacks Investment Research

Bright Health Group (NYSE:BHG – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Monday, Zacks.com reports. According to Zacks, “Bright Health Group is a healthcare company which is building an integrated system of care, in close partnership with our Care Partners. […]

Short Interest in Ark Restaurants Corp. (NASDAQ:ARKR) Decreases By 17.9% - Vimarsana News

Short Interest in Ark Restaurants Corp. (NASDAQ:ARKR) Decreases By 17.9%

Ark Restaurants Corp. (NASDAQ:ARKR – Get Rating) saw a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 9,200 shares, a decline of 17.9% from the March 31st total of 11,200 shares. Currently, 0.5% of the shares of the company are short sold. Based on […]

Short Interest in RealNetworks, Inc. (NASDAQ:RNWK) Increases By 46.9% - Vimarsana News

Short Interest in RealNetworks, Inc. (NASDAQ:RNWK) Increases By 46.9%

RealNetworks, Inc. (NASDAQ:RNWK – Get Rating) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 151,500 shares, an increase of 46.9% from the March 31st total of 103,100 shares. Based on an average trading volume of 250,100 shares, the days-to-cover […]

Analysts Expect Travere Therapeutics, Inc. (NASDAQ:TVTX) Will Announce Quarterly Sales of $53.17 Million - Vimarsana News

Analysts Expect Travere Therapeutics, Inc. (NASDAQ:TVTX) Will Announce Quarterly Sales of $53.17 Million

Equities research analysts forecast that Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Rating) will post sales of $53.17 million for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Travere Therapeutics’ earnings. The highest sales estimate is $55.13 million and the lowest is $49.30 million. Travere Therapeutics reported sales of $47.41 million […]

$2.43 Million in Sales Expected for DURECT Co. (NASDAQ:DRRX) This Quarter - Vimarsana News

$2.43 Million in Sales Expected for DURECT Co. (NASDAQ:DRRX) This Quarter

Analysts expect that DURECT Co. (NASDAQ:DRRX – Get Rating) will report sales of $2.43 million for the current fiscal quarter, Zacks reports. Two analysts have made estimates for DURECT’s earnings. The highest sales estimate is $2.85 million and the lowest is $2.00 million. DURECT reported sales of $2.21 million during the same quarter last year, […]